Apple, Cisco, and IBM are surprisingly cheap income plays for a frothy market.
A small increase in Social Security next year may not be enough to protect you from rising Medicare costs.
An incredibly lucrative sign-up bonus has made the Chase Sapphire Reserve Card a cult hit among credit card aficionados.
Cannabis' competitive landscape is going up in smoke.
According to data from the U.S. Census Bureau, this could put more than $1 million extra in your pocket over your lifetime.
A $200 million stock offering provides financial flexibility, but it also dilutes investors.
These biotech stocks will either make it big or wipe out in spectacular fashion.
Who makes the most popular military helicopters in the world, and which ones should you invest in?
No. 1 is the most important, and No. 5 should convince you that no one can touch the company.
AT&T, GlaxoSmithKline, and Bank of Americas Series D Preferred Stock are the three top holdings in my personal portfolio.
These three stocks all offer intriguing growth that could make them targets of M&A.